Enzon Pharmaceuticals Inc (ENZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,446 | 6,500 | 7,478 | 7,639 | 11,672 |
| Receivables | 485 | 7,970 | N/A | N/A | N/A |
| Other current assets | 62 | 70 | 94 | 270 | 107 |
| TOTAL | $5,993 | $14,540 | $7,572 | $7,909 | $11,779 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 485 | 970 | 1,940 | 3,362 | 11,111 |
| TOTAL | $485 | $970 | $1,940 | $3,362 | $11,111 |
| Total Assets | $6,478 | $15,510 | $9,512 | $11,271 | $22,890 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 324 | 439 | 225 | 770 | 90 |
| Accrued Expenses | 99 | 78 | 143 | 170 | 4,711 |
| TOTAL | $423 | $517 | $368 | $940 | $4,801 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $423 | $517 | $368 | $940 | $4,801 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 44,215 | 44,215 | 44,215 | 44,215 | 44,215 |
| Common Shares | 442 | 442 | 442 | 442 | 441 |
| Retained earnings | -70,077 | -69,098 | -74,947 | -80,392 | -79,266 |
| TOTAL | $6,055 | $14,993 | $9,144 | $10,331 | $18,089 |
| Total Liabilities And Equity | $6,478 | $15,510 | $9,512 | $11,271 | $22,890 |